Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gastric Cancer

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 30 articles: HTML format Text format

Single Articles

October 2019
1. MISAWA K, Mochizuki Y, Sakai M, Teramoto H, et al
   Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
   Br J Surg. 2019 Oct 1. doi: 10.1002/bjs.11303.
   PubMed     Text format     Abstract available
   
   
   September 2019
2. ZHAO Z, Wang Y
   Comment on: Gene expression profiles for a prognostic immunoscore in gastric cancer.
   Br J Surg. 2019;106:1416.
   PubMed     Text format    
   
   
   July 2019
3. BROZA YY, Khatib S, Gharra A, Krilaviciute A, et al
   Screening for gastric cancer using exhaled breath samples.
   Br J Surg. 2019 Jul 1. doi: 10.1002/bjs.11294.
   PubMed     Text format     Abstract available
   
   
   June 2019
4. CHEN AH, Chan WH, Lee YH, Tseng JH, et al
   Routine chest CT for staging of gastric cancer.
   Br J Surg. 2019 Jun 18. doi: 10.1002/bjs.11186.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. VAN PUTTEN M, Nelen SD, Lemmens VEPP, Stoot JHMB, et al
   Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
   Br J Surg. 2018 Aug 22. doi: 10.1002/bjs.10931.
   PubMed     Text format     Abstract available
   
   
   June 2018
6. NAVIDI M, Phillips AW, Griffin SM, Duffield KE, et al
   Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.
   Br J Surg. 2018;105:900-906.
   PubMed     Text format     Abstract available
   
   
   May 2018
7. KANDA M, Shimizu D, Tanaka H, Tanaka C, et al
   Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
   Br J Surg. 2018 May 9. doi: 10.1002/bjs.10876.
   PubMed     Text format     Abstract available
   
   
   
8. CLAASSEN YHM, van Sandick JW, Hartgrink HH, Dikken JL, et al
   Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.
   Br J Surg. 2018;105:728-735.
   PubMed     Text format     Abstract available
   
   
   April 2018
9. ZENG D, Zhou R, Yu Y, Luo Y, et al
   Gene expression profiles for a prognostic immunoscore in gastric cancer.
   Br J Surg. 2018 Apr 25. doi: 10.1002/bjs.10871.
   PubMed     Text format     Abstract available
   
   
   
10. NELEN SD, Bosscha K, Lemmens VEPP, Hartgrink HH, et al
    Morbidity and mortality according to age following gastrectomy for gastric cancer.
    Br J Surg. 2018 Apr 23. doi: 10.1002/bjs.10836.
    PubMed     Text format     Abstract available
    
    
    
11. VAN DER KAAIJ RT, de Rooij MV, van Coevorden F, Voncken FEM, et al
    Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery.
    Br J Surg. 2018;105:561-569.
    PubMed     Text format     Abstract available
    
    
    January 2018
12. MARKAR SR, Mackenzie H, Wiggins T, Askari A, et al
    Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
    Br J Surg. 2018;105:113-120.
    PubMed     Text format     Abstract available
    
    
    
13. POWELL AGMT, Soul S, Christian A, Lewis WG, et al
    Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer.
    Br J Surg. 2018;105:e61-e68.
    PubMed     Text format     Abstract available
    
    
    
14. VAN DER KAAIJ RT, van Kessel JP, van Dieren JM, Snaebjornsson P, et al
    Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2018;105:e176-e182.
    PubMed     Text format     Abstract available
    
    
    December 2017
15. NOBLE F, Lloyd MA, Turkington R, Griffiths E, et al
    Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
    Br J Surg. 2017;104:1816-1828.
    PubMed     Text format     Abstract available
    
    
    
16. KAWAKATSU S, Ohashi M, Hiki N, Nunobe S, et al
    Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer.
    Br J Surg. 2017;104:1829-1836.
    PubMed     Text format     Abstract available
    
    
    November 2017
17. POLOM K, Marano L, Marrelli D, De Luca R, et al
    Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
    Br J Surg. 2017 Nov 1. doi: 10.1002/bjs.10663.
    PubMed     Text format     Abstract available
    
    
    October 2017
18. DENG J, Guo J, Ma G, Zhang H, et al
    Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.
    Br J Surg. 2017 Oct 17. doi: 10.1002/bjs.10628.
    PubMed     Text format     Abstract available
    
    
    September 2017
19. KJAER DW, Larsson H, Svendsen LB, Jensen LS, et al
    Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013.
    Br J Surg. 2017;104:1338-1345.
    PubMed     Text format     Abstract available
    
    
    August 2017
20. NELEN SD, van Putten M, Lemmens VEPP, Bosscha K, et al
    Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Br J Surg. 2017 Aug 9. doi: 10.1002/bjs.10621.
    PubMed     Text format     Abstract available
    
    
    
21. WANG ZX, Li GX, Zhou ZW, Huang ZP, et al
    Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.
    Br J Surg. 2017;104:1226-1234.
    PubMed     Text format     Abstract available
    
    
    May 2017
22. LIN C, Liu H, Zhang H, Cao Y, et al
    Tryptase expression as a prognostic marker in patients with resected gastric cancer.
    Br J Surg. 2017 May 24. doi: 10.1002/bjs.10546.
    PubMed     Text format     Abstract available
    
    
    
23. BENCIVENGA M, Verlato G, Han DS, Marrelli D, et al
    Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.
    Br J Surg. 2017 May 10. doi: 10.1002/bjs.10551.
    PubMed     Text format     Abstract available
    
    
    
24. BUSWEILER LA, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, et al
    Textbook outcome as a composite measure in oesophagogastric cancer surgery.
    Br J Surg. 2017;104:742-750.
    PubMed     Text format     Abstract available
    
    
    February 2017
25. CHANG JS, Kim KH, Yoon HI, Hyung WJ, et al
    Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
    Br J Surg. 2017 Feb 28. doi: 10.1002/bjs.10502.
    PubMed     Text format     Abstract available
    
    
    
26. TOKUNAGA M, Ito S, Yoshikawa T, Nunobe S, et al
    Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
    Br J Surg. 2017 Feb 27. doi: 10.1002/bjs.10509.
    PubMed     Text format     Abstract available
    
    
    January 2017
27. IDA S, Hiki N, Cho H, Sakamaki K, et al
    Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer.
    Br J Surg. 2017 Jan 10. doi: 10.1002/bjs.10417.
    PubMed     Text format     Abstract available
    
    
    
28. TAKAGANE A, Mohri Y, Konishi T, Fukushima R, et al
    Randomized clinical trial of 24 versus 72 h antimicrobial prophylaxis in patients undergoing open total gastrectomy for gastric cancer.
    Br J Surg. 2017;104:e158-e164.
    PubMed     Text format     Abstract available
    
    
    December 2016
29. YANG HK
    Gastric cancer from operating theatre to bench in Korea.
    Br J Surg. 2016;103:e193.
    PubMed     Text format    
    
    
    
30. BUSWEILER LA, Wijnhoven BP, van Berge Henegouwen MI, Henneman D, et al
    Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit.
    Br J Surg. 2016;103:1855-1863.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: